Home   >  
Microbiology/Virology
  >  
CMV

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

CMV

Chemical Structure Cat. No. Product Name CAS No.
Valganciclovir hydrochloride Chemical Structure
 BCP08146 Valganciclovir hydrochloride 175865-59-5
Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.
Valganciclovir Chemical Structure
 BCP28511 Valganciclovir 175865-60-8
Valganciclovir, the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.
Tomeglovir Chemical Structure
 BCP28085 Tomeglovir 233254-24-5
Tomeglovir is a potent anti-CMV agent, inhibiting processing of viral DNA-concatemers, with IC50s of 0.34 μM and 0.039 μM for HCMV and MCMV.
Brivudine Chemical Structure
 BCP09009 Brivudine 69304-47-8
Brivudine was shown to be a potent inhibitor.
Cidofovir dihydrate Chemical Structure
 BCP07716 Cidofovir dihydrate 149394-66-1
Cidofovir dihydrate is the dihydrate of the anhydrous form of cidofovir. A nucleoside analogue, it is an injectable antiviral used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients.
Cidofovir Chemical Structure
 BCP03734 Cidofovir 113852-37-2
Cidofovir suppresses virus replication by selective inhibition of viral DNA synthesis.
Brincidofovir Chemical Structure
 BCP08580 Brincidofovir 444805-28-1
CMX001 (hexadecyloxypropyl cidofovir, HDP-CDV) was developed as an orally active, lipophilic form of cidofovir (CDV). It has enhanced activity in vitro and in vivo compared to CDV against certain herpesviruses, adenoviruses and orthopoxviruses.CMX001 is currently in Phase II clinical studies for development as a therapeutic agent for human CMV, adenovirus and BK virus infections, as well as, for adverse events following smallpox vaccinations.
Maribavir Chemical Structure
 BCP09373 Maribavir 176161-24-3
Maribavir(GW257406X; BW1263W94; 1263W94) inhibits HCMV replication is by inhibition of an HCMV encoded protein kinase enzyme called UL97 or pUL97.
Letermovir Chemical Structure
 BCP28231 Letermovir 917389-32-3
Letermovir is a novel inhibitor of CMV, which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.
共 9 条记录 1 / 1 页
0086-13720134139